Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

Valentina Polo; Giulia Pasello; Stefano Frega; Adolfo Favaretto; Haralabos Koussis; Pierfranco Conte; Laura Bonanno

doi:10.18632/oncotarget.7732

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

Valentina Polo, Giulia Pasello, Stefano Frega, Adolfo Favaretto, Haralabos Koussis, Pierfranco Conte and Laura Bonanno _

PDF | HTML | How to cite

Oncotarget. 2016; 7:25050-25063. https://doi.org/10.18632/oncotarget.7732

Metrics: PDF 2845 views | HTML 3039 views | ?

Abstract

Valentina Polo1,2, Giulia Pasello1, Stefano Frega1, Adolfo Favaretto1, Haralabos Koussis1, Pierfranco Conte1,2 and Laura Bonanno1

1 Medical Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy

2 Department of Surgery, Oncology and Gastroenterology, Università degli Studi di Padova, Padova, Italy

Correspondence to:

Laura Bonanno, email: laura.bonanno@ioveneto.it

Keywords: squamous cell carcinoma, lung, head and neck, smoke, HPV

Received: October 08, 2015 Accepted: January 29, 2016 Published: February 25, 2016

Abstract

Squamous cell carcinomas of the lung and of the head and neck district share strong association with smoking habits and are characterized by smoke-related genetic alterations. Driver mutations have been identified in small percentage of lung squamous cell carcinoma. In parallel, squamous head and neck tumors are classified according to the HPV positivity, thus identifying two different clinical and molecular subgroups of disease.

This review depicts different molecular portraits and potential clinical application in the field of targeted therapy, immunotherapy and chemotherapy personalization.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7732

Publication Alerts

Oncoscience

Post-Publication Promotion

Reviews:

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization

Abstract